Skip to main content
The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.
Default Author Avatar IUSM Logo

Ben Middelkamp

Ben Middelkamp is a communications manager for the Department of Neurology, Department of Neurological Surgery and Stark Neurosciences Research Institute at Indiana University School of Medicine. Before joining the Office of Strategic Communications in December 2019, Ben spent nearly six years as a newspaper reporter in two Indiana cities. He earned a bachelor’s degree in Convergent Journalism from Indiana Wesleyan University in 2014. Ben enjoys translating his background in journalism to the communications and marketing needs of the school and its physicians and researchers.

Showing results for Ben Middelkamp

Graduate and medical students form science policy and communication group focused on Alzheimer's disease research

Doctoral and medical students at IU School of Medicine and Marian University College of Osteopathic Medicine founded IMPACT Indiana, a group centered on health policy and science communication, specifically focusing on Alzheimer’s disease research.

Ben Middelkamp  |  Apr 08, 2024

Alzheimer's disease researcher awarded Rainwater Charitable Foundation early-career scientist prize

Cristian Lasagna-Reeves, PhD received the prestigious 2024 Rainwater Prize for Innovative Early-Career Scientist. Lasagna-Reeves was presented the award at the Alzheimer’s Association’s Tau2024 Global Conference on March 25, 2024 in Washington, D.C.

Ben Middelkamp  |  Mar 28, 2024

Medical Neuroscience Graduate Organization educating about ocular health for April 8 solar eclipse

A group of Indiana University School of Medicine trainees in the Medical Neuroscience Graduate Program at Stark Neurosciences Research Institute is teaming up with fellow scientists from the Eugene and Marilyn Glick Eye Institute to host a lecture about the science behind solar eclipses and their impact on ocular health.

Ben Middelkamp  |  Mar 25, 2024

Nation's largest early-onset Alzheimer's study drives diversity

LEADS, led by Liana Apostolova, MD, has received $78 million in National Institute of Aging (NIA) funding since it launched in 2018. It's also the largest National Institutes of Health grant at IU School of Medicine in 2023 at $13.9 million.

Ben Middelkamp  |  Mar 13, 2024

Reprogramming cell in adult central nervous system promotes regeneration of motor function axons after spinal cord injury

Led by Wei Wu, PhD, assistant professor of neurological surgery and a primary member of Stark Neurosciences Research Institute, the researchers discovered a connection between the reprogramming of NG2 glial cells and robust axonal regeneration after spinal cord injury.  

Ben Middelkamp  |  Mar 06, 2024

Neuroscientists receive NIH grants to investigate brain’s role in addiction, anxiety and obesity

Three Indiana University School of Medicine researchers each received National Institutes of Health grant funding to study under-explored mechanisms and connections in the brain using animal models. Through their investigations, they hope to discover therapeutic targets to treat health conditions, including obesity, anxiety and alcohol use disorder. The faculty investigators are members of the addiction research interest group at Stark Neurosciences Research Institute.

Ben Middelkamp  |  Jan 30, 2024

Glaucoma research program growing at IU School of Medicine

Glick Eye Institute researchers Arupratan Das, PhD, Padmanabhan Pattabiraman, PhD, Weiming Mao, PhD and Tasneem Sharma, PhD—also members of the ocular neurobiology research interest group at Stark Neurosciences Research Institute— are exploring ways to prevent and treat the disease.

Ben Middelkamp  |  Jan 22, 2024

Neurologists at IU administer first-of-its-kind FDA-approved gene therapy

Neurologists at Indiana University School of Medicine are among the first clinicians in the nation to administer a groundbreaking gene-based therapy for patients living with a rare form of amyotrophic lateral sclerosis (ALS).

Ben Middelkamp  |  Jan 05, 2024

IU administering, leading clinical research on FDA-approved Alzheimer’s drug

For nearly a decade, lecanemab has been tested in clinical trials at IU School of Medicine—the newly FDA-approved drug is now being administered to patient at IU Health. The drug targets the removal of amyloid plaques in the brain—a hallmark of Alzheimer’s disease.

Ben Middelkamp  |  Nov 13, 2023

Neurology postdoctoral scholar awarded first Alzheimer's Association Perelman Fellowship

The Alzheimer’s Association recently named Kate Foley, PhD, postdoctoral fellow in the Department of Neurology at Indiana University School of Medicine, as the inaugural Dr. Mel Perelman Fellow for Alzheimer’s Research.

This research fellowship, named in honor of the late Mel Perelman, PhD, a former executive of Eli Lilly and Company, will be awarded annually to an IU School of Medicine researcher who has been vetted and selected by the Alzheimer’s Association’s Medical and Scientific Advisory Group to receive a research grant.

Ben Middelkamp  |  Oct 20, 2023